Abstract:Introduction: Many breast cancer patients suffer from fear of cancer recurrence (FCR). However, effective physical intervention for FCR has been scarce. Previous studies have confirmed that repetitive transcranial magnetic stimulation (rTMS) can help improve patients' anxiety, depression, fear, and stress level. Therefore, this study aims to assess the efficacy of rTMS in the treatment of FCR in breast cancer patients and explore its underlying neural mechanism. Methods and analysis: and analysis: Fifty breast cancer patients with high FCR (FCR total score >27), and fifty age- and gender-matched patients with low FCR (FCR total score <7) will be recruited to participate in this study. Patients in the high FCR group will be randomly assigned to receive 4-week low-frequency rTMS targeting the right dorsolateral prefrontal cortex (rDLPFC) + treatment as usual (TAU) (n = 25), or to receive sham stimulation + TAU (n = 25). Patients in the low FCR group will only receive TAU. All participants will take a baseline fMRI scan to examine the local activities and interactions of brain activity between the prefrontal cortex (DLPFC), amygdala and hippocampus. Fear of Cancer Recurrence Questionnaire (FCRQ7), Patient Health Questionnaire (PHQ9), Generalize Anxiety Disorder (GAD7), Numeric Rating Scale (NRS), and Insomnia Severity Index (ISI7) will be used to measure an individual's FCR, depression, anxiety, pain, and insomnia symptoms at week 0 (baseline), week 4 (the end of intervention), week 5 (1 week post-treatment), week 8 (1 month post-treatment), and week 16 (3 months post-treatment). Participants in the high FCR group will receive a post-treatment fMRI scan within 24 h after intervention to explore the neural mechanisms of rTMS treatment. The primary outcome of the study, whether the rTMS intervention is sufficient in relieving FCR in breast cancer patients, is measured by FCRQ7. Additionally, task activation, local activity and functional connectivity of the DLPFC, amygdala and hippocampus will be compared, between high and low FCR group, and before and after treatment. Discussion: Studies have shown that low-frequency rTMS can be used to treat patient's FCR. However, there is a lack of relevant evidence to support the efficacy of rTMS on FCR in cancer patients, and the neural mechanisms underlying the effects of rTMS on FCR need to be further investigated. Ethics and dissemination: Ethical approval for the study has been obtained from the Ethics Committee of Guangdong Provincial People's Hospital (reference number: KY-N-2022-136-01). The results of the investigation will be published in scientific papers. The data from the investigation will be made available online if necessary. Trial registration: NCT05881889 (ClinicalTrials.gov). Date of registration: May 31, 2023.

Regional Homogeneity And Homotopic Connectivity Changes In Breast Cancer Survivors With Fear of Cancer Recurrence: A Resting State FMRI Study

Altered regional homogeneity and homotopic connectivity in Chinese breast cancer survivors with fear of cancer recurrence: A resting-state fMRI study

Resting State Functional Connectome in Breast Cancer Patients with Fear of Cancer Recurrence.

Distinguishing Hypochondriasis and Schizophrenia Using Regional Homogeneity: a Resting-State Fmri Study and Support Vector Machine Analysis.

Decreased Regional Homogeneity and Increased Functional Connectivity of Default Network Correlated with Neurocognitive Deficits in Subjects with Genetic High-Risk for Schizophrenia: A Resting-State Fmri Study.

Latent profile analysis and related factors of fear of cancer recurrence among Chinese breast cancer patients in rehabilitation

Effects of repetitive transcranial magnetic stimulation on fear of cancer recurrence and its underlying neuromechanism

Effects of fear of cancer recurrence on subjective physical and mental health in breast cancer patients: The intermediary role of heart rate variability

The abnormalities of regional homogeneity in the resting-state of first-episode medication-na(i)ve schizophrenia

Core Fear of Cancer recurrence symptoms in Cancer Survivors: a network approach

Predictors and Trajectories of Fear of Cancer Recurrence in Chinese Breast Cancer Patients

Study regional homogeneity and low frequency amplitude of brain resting state functional magnetic resonance imaging in patients with depression

Relationship Between Regional Homogeneity of Depressed Patients and Anxious Symptoms: a Resting-State Fmri Study

Network connectivity between fear of cancer recurrence, anxiety, and depression in breast cancer patients

Relationship between Regional Homogeneity and Separate Symptom Clusters of Depression:a Resting-state fMRI Study.

Preoperative early-stage lung cancer patients and local brain area changes: a cross-sectional observational descriptive study

Latent Profiles of Fear of Cancer Recurrence in Breast Cancer Patients of Reproductive Age and Associations With Reproductive Concerns

Disrupted Regional Homogeneity In Treatment-Resistant Depression: A Resting-State Fmri Study

The Association Between Metacognition, Coping Style and Fear of Cancer Recurrence among Postmastectomy Patients: A Cross Sectional Study.

Correlation between symptom experience and fear of cancer recurrence in postoperative breast cancer patients undergoing chemotherapy in China: A cross-sectional study

Network-level functional connectivity alterations in chemotherapy treated breast cancer patients: a longitudinal resting state functional MRI study